Arteris, Inc. (NASDAQ:AIP – Get Free Report) VP Paul Alpern sold 4,000 shares of the firm’s stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $30.04, for a total value of $120,160.00. Following the sale, the vice president directly owned 70,733 shares of the company’s stock, valued at $2,124,819.32. This trade represents a 5.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Arteris Stock Down 3.6%
Shares of NASDAQ AIP traded down $1.16 during trading hours on Wednesday, hitting $30.93. The stock had a trading volume of 521,833 shares, compared to its average volume of 734,745. The company has a market capitalization of $1.43 billion, a P/E ratio of -39.15 and a beta of 1.96. The firm’s 50-day moving average price is $36.29 and its two-hundred day moving average price is $25.97. Arteris, Inc. has a 52 week low of $8.42 and a 52 week high of $50.26. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.73 and a current ratio of 0.73.
Arteris (NASDAQ:AIP – Get Free Report) last issued its quarterly earnings data on Tuesday, May 12th. The company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.05. The business had revenue of $22.94 million for the quarter, compared to the consensus estimate of $21.03 million. Analysts anticipate that Arteris, Inc. will post -0.6 EPS for the current fiscal year.
Hedge Funds Weigh In On Arteris
Analysts Set New Price Targets
A number of research analysts have recently weighed in on AIP shares. Wall Street Zen downgraded shares of Arteris from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Roth Capital assumed coverage on shares of Arteris in a report on Tuesday. They issued a “buy” rating and a $40.00 price objective for the company. Northland Securities set a $38.00 target price on shares of Arteris in a research report on Wednesday, May 13th. TD Cowen raised their target price on Arteris from $22.00 to $40.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Finally, Jefferies Financial Group boosted their price target on Arteris from $16.00 to $35.00 and gave the stock a “hold” rating in a research report on Wednesday, May 13th. Four investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $38.50.
Check Out Our Latest Stock Report on AIP
Arteris Company Profile
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Recommended Stories
- Five stocks we like better than Arteris
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
